Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005586 |
ID: | TCMBANKHE005586 |
植物拉丁名: |
|
功能与主治: | 1. To drain accumulated cold downward; 2. To transform water and reduce edema; 3. To resolve phlegm and benefit throat/Distention fullness and sudden pain in chest and a bdomen, fecal stoppage, diarrhea and dysentery, edema and enlarged abdomen, phlegm-rheum asthma fullness, throat wind, throat impediment, concretion and conglomeration, welling abscess and flat abscess, malign sore and scab lichen. |
药用植物名: | 巴豆 |
药用部位: | dried seed |
药味: | Hot; Pungent |
经络: | Large Intestine; Stomach |
毒性: | Extremely Toxic |
治疗类型: | 攻下药 |
TCM_ID_id: | 4179;2030 |
SymMap_id: | 6 |
TCMSP_id: | 7 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000100 | lauric acid | NCGC00090919-01; CHEBI:30805; n-Dodecanoic acid; Hydrofol acid 1255; Wecoline 1295; Neo-Fat 12-43; 8045-27-0; WLN: QV11; AI3-00112; AIDS-049202; 61609_FLUKA; Dodecylcarboxylate; DAO; EINECS 205-582-1; L-ALFA-LYSOPHOSPHATIDYLCHOLINE, LAUROYL; CCRIS 669; W261408_ALDRICH; lauric acid ; 8000-62-2; DODECANOIC ACID (LAURIC ACID); C-1297; 7632-48-6; ST023796; NSC5026; Laurinsaeure; C02679; [2-((1-OXODODECANOXY-(2-HYDROXY-3-PROPANYL))-PHOSPHONATE-OXY)-ETHYL]-TRIMETHYLAMMONIUM; Dodecoic acid; Laurostearic acid; NCGC00090919-02; 4-02-00-01082 (Beilstein Handbook Reference); lauricacid; Ninol AA62 extra; InChI=1/C12H24O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2-11H2,1H3,(H,13,14; Lauric acid (natural); Aliphat No. 4; NSC-5026; Coconut oil fatty acids; Lauric acid, pure; 203714-07-2; NCIOpen2_009480; CH3-[CH2]10-COOH; Dodecylic acid; Neo-Fat 12; AIDS049202; C12 fatty acid; HSDB 6814; Dodecanoic acid; L556_ALDRICH; Lauric acid; LAP; Univol U-314; FEMA No. 2614; 1-Undecanecarboxylic acid; Vulvic acid; 143-07-7; BRN 1099477; Duodecylic acid; LAU; W261416_ALDRICH; LMFA01010012; L4250_SIGMA; Hydrofol acid 1295 | C12H24O2 | 200.32 | CCCCCCCCCCCC(=O)O |
| TCMBANKIN001711 | AIDS161753 | 5H-Cyclopropa[3,4]benz[1,2-e]azulen-5-one, 1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-7b,9,9a-trihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-, (1aR,1bS,4aR,7aR,7bR,8R,9R,9aS)-; AIDS-161753 | C20H28O5 | 348.43 | CC1C(C2(C(C2(C)C)C3C1(C4C=C(C(=O)C4CC(=C3)CO)C)O)O)O |
| TCMBANKIN003317 | croton oil | ||||
| TCMBANKIN004822 | Phorbol caprate, tiglate | (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-9-{[(2E)-2-methylbut-2-enoyl]oxy}-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl decanoate; phorbol 13-decanoate 12-tiglate; Phorbol monodecanoate mono(2-methylcrotonate), (E)-; Phorbol 12-tiglate 13-decanoate; Phorbol 12-tiglate 13-decanonate; 59086-92-9; C09157; CHEBI:28366; 5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one, 1,1a-beta,1b-alpha,4,4a,7a-beta,7b,8,9,9a-decahydro-4a-alpha,7b-beta,9-alpha,9a-beta-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-beta-tetramethyl-, 9a-decanoate 9-(2-methylcrotonate) | C35H52O8 | 600.78 | CCCCCCCCCC(=O)OC12C(C1(C)C)C3C=C(CC4(C(C3(C(C2OC(=O)C(=CC)C)C)O)C=C(C4=O)C)O)CO |
| TCMBANKIN007431 | Linoleyl acetate | octadeca-9,12-dien-1-yl acetate; acetic acid [(9E,12E)-octadeca-9,12-dienyl] ester; [(9E,12E)-octadeca-9,12-dienyl] ethanoate; 5999-95-1; FT-0635935; linoleyl acetate; [(9E,12E)-octadeca-9,12-dienyl] acetate | C20H36O2 | 308.5 | CCCCCC=CCC=CCCCCCCCCOC(=O)C |
| TCMBANKIN012992 | trachyloban-19-oicacid | C20H30O2 | 302.5 g/mol | CC12CCCC(C1CCC34C2CC5C(C3)C5(C4)C)(C)C(=O)O | |
| TCMBANKIN016721 | phorbol diester | CCCC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)OC(=O)CCC)O)C | |||
| TCMBANKIN017180 | tiglic acid | NSC8999; trans-2,3-Dimethylacrylic acid; ST5307929; Tiglinic acid; alpha-Methylcrotonic acid, (E)-; trans-2-Methylcrotonic acid; EINECS 236-167-3; 2-methyl-2E-butenoic acid; 2-Butenoic acid, 2-methyl-, (E)-; alpha,beta-dimethyl acrylic acid; (E)-2-methylbut-2-enoate; 4-02-00-01552 (Beilstein Handbook Reference); A839954; alpha-methylcrotonic acid; EINECS 201-295-0; CHEBI:9592; Tiglinsaeure; C08279; (E)-2-Methylcrotonic acid; 2-Methyl-2-butenoic acid; 2-Butenoic acid, 2-methyl-; BRN 1236500; tiglicacid; trans-.alpha.,.beta.-Dimethylacrylic acid; (E)-2-Methyl-2-butenoic acid; NSC44235; 13201-46-2; (E)-2,3-Dimethylacrylic acid; 2-Methyl-2-butenoic acid, (E)-; FEMA No. 3599; (E)-2-Methylbut-2-enoic acid; Crotonic acid, 2-methyl-, (E)-; Cevadic acid; (2E)-2-methylbut-2-enoic acid; 89450_FLUKA; T35203_ALDRICH; 2-methylbut-2-enoic acid; 2,3-Dimethylacrylic acid, (E)-; AI3-36118; NSC 44235; 2-Butenoic acid, 2-methyl-, (E)- (9CI); (E)-2-methyl-2-Butenoate; 2-Butenoic acid, 2-methyl-, (2E)-; Tiglic acid; LMFA01020030; AC1ODZB2; trans-alpha,beta-Dimethylacrylic acid; W359904_ALDRICH; Crotonic acid, 2-methyl-; 80-59-1; trans-2-Methyl-2-butenoic acid; CHEBI:36432 | C5H8O2 | 100.12 g/mol | CC=C(C)C(=O)O |
| TCMBANKIN017993 | vitamin c | D01CWN; Cell C; Ronotec 100; P 1110; Suncoat VC 40; D-threo-hex-2-enoic acid gamma-lactone; Citrovit; 2-o-(beta-d-glucopyranosyl)-ascorbic acid_qt; Juvamine; SCHEMBL13468284; Vasc; CHEBI:51384; D-Lyxoascorbic acid; CHEMBL1253320; AK481251; Chewcee; D-xyloascorbic acid; C8DQ5M1Y1E; MLS001066386; AK322241; Ascorbic acid, D-; AC1LD8K5; E 300; Scorbu C; 10504-35-5; Ascorbicacid; l(+)-ascorbic acid; ZINC100006137; L-ascorbate (vitamin C); (5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one; (+)-Ascorbic acid; UNII-C8DQ5M1Y1E; Ascorbinsaure; Ceklin; VC 97; (2S)-2-[(1R)-1,2-bis(oxidanyl)ethyl]-4,5-bis(oxidanyl)furan-3-one; Vicin; L-ascorbate acid; L-ascorbic acid; L-dehydroascorbic acid; ascorbate; D-threo-hex-2-enono-1,4-lactone; Kangbingfeng; D-Ascorbic acid; Viscorin 100M; ZINC100028197; (2S)-2-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxy-3-furanone; L-Ascorbic acid (8CI,9CI); Proscorbin Redoxon Ribena Ronotec 100; Hex-2-enonic acid gamma-lactone, L-threo; (5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one; Ascorbic acid; DL-Ascorbic acid; AKOS000278050; Cebion, gamma-lactone; F91F7DA3-A3D5-4FB4-A6E7-C497C48D192A; GTPL4651; SMR000471843; Xyloascorbic acid, L-; Rontex 100; Rovimix C; (2S)-2-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one; A828310 | C6H8O6 | 176.12 | C(C(C1C(=C(C(=O)O1)O)O)O)O |
| TCMBANKIN018224 | l-pipecilic acid | ||||
| TCMBANKIN019058 | Morindin | 1,5-Dihydroxy-2-methyl-6-((6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy)-9,10-anthracenedione; DTXSID60209193; 1,5-dihydroxy-2-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione; morindin; 1,5-dihydroxy-2-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione; 60450-21-7; AC1L46PF; 1,5-dihydroxy-2-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-9,10-anthraquinone; 1,5-dihydroxy-2-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxymethyl]oxan-2-yl]oxy-anthracene-9,10-dione; 1,5-dihydroxy-2-methyl-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxy]anthracene-9,10-dione; D56N4L816F; 1,5-dihydroxy-2-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-anthracene-9,10-dione; 9,10-Anthracenedione, 1,5-dihydroxy-2-methyl-6-((6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy)-; Morindone 6-beta-primeveroside; UNII-D56N4L816F | C26H28O14 | 564.49 | CC1=C(C2=C(C=C1)C(=O)C3=C(C2=O)C=CC(=C3O)OC4C(C(C(C(O4)COC5C(C(C(CO5)O)O)O)O)O)O)O |
| TCMBANKIN020952 | phytoagglutinin | ||||
| TCMBANKIN022517 | 3-(3,4-dihydroxyphenyl)-1-(5-hydroxy-2,2-dimethylchromen-6-yl)propan-1-one | 3-(3,4-dihydroxyphenyl)-1-(5-hydroxy-2,2-dimethyl-6-chromenyl)propan-1-one; 3-(3,4-dihydroxyphenyl)-1-(5-hydroxy-2,2-dimethyl-chromen-6-yl)propan-1-one | C20H20O5 | 340.4 g/mol | CC1(C=CC2=C(O1)C=CC(=C2O)C(=O)CCC3=CC(=C(C=C3)O)O)C |
| TCMBANKIN022980 | caprylic acid | Octanoic acid (mixed isomers); AK405365; octoic acid; Sodium octanoate, 96%; Natrium octanoat; D05220; NoO notEa AAENI; W279927_ALDRICH; Sodium caprylate [NF]; KB-80641; ACMC-1BO0W; MCULE-8227046407; AIDS-006110; Caprylsaeure; V0353; Octylic acid; Enantic acid; Caprylic acid sodium salt; Sodium n-octanoate; Sodium octoate; Octanoic acid sodium salt; 68937-74-6; MolPort-006-113-836; EINECS 273-085-7; C-8 acid; 21639_FLUKA; HSDB 5862; AIDS006110; NCGC00090957-02; 0ctanoic acid; BYKRNSHANADUFY-UHFFFAOYSA-M; Acid C-8; caprylic acid, sodium salt; 124-07-2; Acido octanoico [Spanish]; Sodium octanoate, 96% 100g; Octic acid; 124-07-2 (Parent); W279900_ALDRICH; KS-00000YJH; capryloate; Sodium caprylate: Octanoic acid; NCGC00090957-01; Acide octanoique [French]; Sodium caprylate (NF); O0034; UNII-9XTM81VK2B; LS-98001; 18312-04-4; neo-fat 8; OCTANOIC ACID (CAPRYLIC ACID); SODIUM OCTANOATE; 1-heptanecarboxylic acid; NCIOpen2_009358; LS-691; O3907_ALDRICH; 1984/6/1; CHEBI:132100; MFCD00058511; AN-19785; ANW-13619; NCIOpen2_002902; octanoic acid; C2875_SIGMA; I14-14709; TR-009215; Caprylic acid (natural); NSC 5024; CHEBI:28837; Octanoic acid [USAN:INN]; LMFA01010008; n-octylic acid; TRA-0206488; Fatty acids, C6-1O; FEMA No. 2799; BRN 1747180; 4-02-00-00982 (Beilstein Handbook Reference); 9XTM81VK2B; EINECS 204-677-5; CHEMBL557076; Octanoic acid, sodium salt; EINECS 217-850-5; ST51037190; KSC490S9T; caprylic acid ; NSC5024; AI3-50473; SCHEMBL56211; Sodium Salt of Caprylic Acid; Octanoic acid (USAN); Hexacid 898; CH3-[CH2]6-COOH; Sodium caprylate; Sodium caprylate [USAN]; RTR-009215; 27633_RIEDEL; Kaprylsaeure; C06423; Fatty acids, C6-10; caprylicacid; Acidum octanocium [Latin]; HSDB 821; AI3-04162; Kyselina kaprylova [Czech]; n-octanoic acid; FT-0701289; n-caprylic acid; AS-17478; CCRIS 4689; PubChem12870; 21650_FLUKA; n-Octoic acid; W-109735; CTK3J0999; AKOS015901906; OCA; Octansaeure; SC-79959; n-Octanoic Acid Sodium Salt; WLN: QV7; CPD-195; Octanoic acid, sodium salt (1:1); DTXSID3027451; D08999 | C8H16O2 | 144.21 g/mol | CCCCCCCC(=O)O |
| TCMBANKIN023856 | officinalisin | C11H20O6 | 248.27 | ||
| TCMBANKIN025281 | phytin | Phytin; P0410; 3615-82-5 | C6H6Ca6Mg6O24P6 | 1034.2 g/mol | C1(C(C(C(C(C1OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Ca].[Ca].[Ca].[Ca].[Ca].[Ca] |
| TCMBANKIN025313 | croton resin | ||||
| TCMBANKIN025845 | lectins | ||||
| TCMBANKIN027920 | pipecolic acid | pipecolic acid ; pipecolicacid | C6H11NO2 | 129.16 g/mol | C1CCNC(C1)C(=O)O |
| TCMBANKIN029431 | 3α,21α,22α,28-tetrahydroxyolean-12-ene-28-O-β-D-xylopyranoside | 606.93 | |||
| TCMBANKIN030333 | anthocyanidin | 251.22 | C1=CC=C(C=C1)C2=[O+]C3=CC=CC=C3C=C2.[O-]Cl(=O)(=O)=O | ||
| TCMBANKIN030386 | trachyloban-18-oicacid | C20H30O2 | 302.5 g/mol | CC12CCCC(C1CCC34C2CC5C(C3)C5(C4)C)(C)C(=O)O | |
| TCMBANKIN031010 | ETHYLMYRISTATE | Myristic acid, ethyl ester; tetradecanoic acid ethyl ester; 124-06-1; E39600_ALDRICH; 70090_ALDRICH; NSC8917; Myristic acid, ethyl ester (8CI); myristic acid ethyl ester; Tetradecanoic acid, ethyl ester; AI3-01024; Ethyl tetradecanoate; Ethyl myristate; NSC 8917; FEMA No. 2445; Ethyl myristate (natural); W244503_ALDRICH; EINECS 204-675-4 | C16H32O2 | 256.42 | CCCCCCCCCCCCCC(=O)OCC |
| TCMBANKIN031507 | [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (E)-2-methylbut-2-enoate | (E)-2-methylbut-2-enoic acid [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester | C13H21NO2 | 223.31 | |
| TCMBANKIN034847 | crotin i, ii | ||||
| TCMBANKIN036063 | cocarcinogens | ||||
| TCMBANKIN036312 | 20-Hexadecanoylingenol | 20-hexadecanoylingenol | C36H58O6 | 586.94 | CCCCCCCCCCCCCCCC(=O)OCC1=CC2C3C(C3(C)C)CC(C4(C2=O)C=C(C(C4(C1O)O)O)C)C |
| TCMBANKIN036901 | myristic acid | 1-Tridecanecarboxylic acid; Myristinsaeure; CH3-[CH2]12-COOH; 70079_FLUKA; AI3-15381; LMFA01010014; CH3-[CH2]12-COO(-); NCGC00091068-02; Myristic acid-[9,10-3H]; C06424; Emery 655; myristic acid ; NSC 5028; 70082_FLUKA; C14 fatty acid; ST023797; W276405_ALDRICH; CCRIS 4724; Kortacid 1499; 3uev; TUNFSRHWOTWDNC-UHFFFAOYSA-M; Tetradecanoic acid; EINECS 250-924-5; n-Tetradecoic acid; 4-02-00-01126 (Beilstein Handbook Reference); Hydrofol acid 1495; MYR; BRN 0508624; Myristate; Myristic acid (natural); Tetradecanoate; LS-190125; Crodacid; Myristic acid (8CI); EINECS 208-875-2; Prifac 2942; Myristic acid; AIDS002505; tetradecoate; W276413_ALDRICH; FEMA No. 2764; HSDB 5686; Philacid 1400; CHEBI:28875; Edenor C 14; n-tetradecoate; 45184-05-2; myristicacid; tetradecoic acid; n-Tetradecanoic acid; M3128_SIGMA; AIDS-002505; Univol U 316S; Lead dimyristate; AC1N2PSK; NCGC00091068-01; neo-Fat 14; NSC5028; Tetradecanoic acid (9CI); Hystrene 9014; Myristic acid, pure; M4792_SIGMA; CHEBI:30807; n-Tetradecan-1-oic acid; WLN: QV13; 1-tetradecanecarboxylate; 32112-52-0; n-tetradecan-1-oate; 544-63-8 | C14H28O2 | 228.371 | C([H])([H])(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] |
| TCMBANKIN036940 | Phrymarolin-II | phrymarolin-ii; [(3R)-3-(1,3-benzodioxol-5-yloxy)-6-(6-methoxy-1,3-benzodioxol-5-yl)-3,4,6,6a-tetrahydro-1H-furo[3,4-c]furan-3a-yl] acetate; AC1NSZLL | C23H22O10 | 458.41 | CC(=O)OC12COC(C1COC2OC3=CC4=C(C=C3)OCO4)C5=CC6=C(C=C5OC)OCO6 |
| TCMBANKIN037060 | Isoguanine | NSC 241501; isoguanine; 6-amino-1,7-dihydropurin-2-one; AC1L8Z4F; 2H-Purin-2-one, 6-amino-1,3-dihydro- (9CI); ZINC04764156; NSC241501; 6-Amino-1,3-dihydro-2H-purin-2-one; 2H-Purin-2-one, 6-amino-1,3-dihydro-; 6-amino-3,5-dihydropurin-2-one; 6-Amino-3,9-dihydro-purin-2-one; ST5298861; SR-01000637365-1; ZINC01023252; AIDS045535; 3373-53-3; EINECS 222-157-6; AIDS-045535 | 151.13 | ||
| TCMBANKIN037186 | 12-O-Decanoylphorbol-13-(2-methylbutyrate) | AC1L9V6Y; Decanoic acid,(1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-9a-(2-methyl-1-oxobutoxy)-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-ylester (9CI); 12-O-Decanoylphorbol-13-(2-methylbutyrate); Decanoic acid, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-9a-(2-methyl-1-oxobutoxy)-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester; [dihydroxy-(hydroxymethyl)-tetramethyl-(2-methylbutanoyloxy)-oxo-[?]yl] decanoate; 250268-56-5; Decanoic acid, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-9a-(2-methyl-1-oxobutoxy)-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester; CTK4F4839 | 602.8 g/mol | ||
| TCMBANKIN038004 | Phorbol-12-palmitate-13-acetate | ||||
| TCMBANKIN038121 | 13-O-tigloylphorbol-20-linoleate | 13-O-Tigloylphorbol-20-linoleate; 9,12-Octadecadienoic acid (9Z,12Z)-, ((1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b,9-trihydroxy-1,1,6,8-tetramethyl-9a-(((2E)-2-methyl-1-oxo-2-butenyl)oxy)-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-3-yl)methyl ester; [trihydroxy-tetramethyl-[(E)-2-methylbut-2-enoyl]oxy-oxo-[?]yl]methyl (9Z,12Z)-octadeca-9,12-dienoate; 250268-54-3; 9,12-Octadecadienoic acid (9Z,12Z)-, [(1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b,9-trihydroxy-1,1,6,8-tetramethyl-9a-[[(2E)-2-methyl-1-oxo-2-butenyl]oxy]-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-3-yl]methyl ester | C43H64O8 | 709 | [C@]12([H])[C@@](O[H])(C(=O)C(C([H])([H])[H])=C1[H])C([H])([H])C(C([H])([H])OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])\C([H])=C([H])/C([H])([H])\C([H])=C([H])/ C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])=C([H])[C@]3([H])[C@]2(O[H])[C@]([H])(C([H])([H])[H])[C@@]([H])(O[H])[C@@](OC(=O)\C(=C([H])\C([H])([H])[H])\C([H])([H])[H])(C4(C([H])([H])[H] )C([H])([H])[H])[C@]34[H] |
| TCMBANKIN038143 | stachyose | O-alpha-D-galactopyranosyl-(1->6)o-alpha-D-galactopyranosyl-(1->6)O-alpha-D-galactopyranosyl-beta-D-fructofuranoside; 10094-58-3; C01613; Stachyose; beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside; 470-55-3; alpha-D-Galp-(1->6)-alpha-D-Galp-(1->6)-alpha-D-Glcp-(1<->2)-beta-D-Fruf; (2R,3R,4S,5S,6R)-2-[[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)-2-tetrahydrofuranyl]oxy]-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxymethyl]tet; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxane-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl]oxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxymethyl]tetra; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-dimethylol-tetrahydrofuran-2-yl]oxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-3,; CHEBI:17164 | C24H42O21 | 667 | O([H])[C@]1([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(OC([H])([H])[C@]2([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[C@]3([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H] )O[H])O[C@]3([H])O[C@]4([C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O4)C([H])([H])O[H])O2)O[C@]1([H])C([H])([H])O[H] |
| TCMBANKIN039445 | 12-O-Tigloylphorbol-13-(2-methylbutyrate) | [dihydroxy-(hydroxymethyl)-tetramethyl-[(Z)-2-methylbut-2-enoyl]oxy-oxo-[?]yl] 2-methylbutanoate; 2-Butenoic acid, 2-methyl-, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-9a-(2-methyl-1-oxobutoxy)-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester, (2E)-(; 12-O-Tigloylphorbol-13-(2-methylbutyrate); 250268-57-6; 2-Butenoic acid, 2-methyl-, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-9a-(2-methyl-1-oxobutoxy)-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester, (2E)- ( | 531 | ||
| TCMBANKIN040034 | 3α,19-dihydroxy trachylobane | C20H32O2 | |||
| TCMBANKIN040104 | 12-O-acetylphorbol-13-tigliate | 2-Butenoic acid, 2-methyl-, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9-(acetyloxy)-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-9aH-cyclopropa(3,4)benz(1,2-e)azulen-9a-yl ester, (2E)-(; 12-O-Acetylphorbol-13-tigliate; 250268-55-4; 2-Butenoic acid, 2-methyl-, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9-(acetyloxy)-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-9aH-cyclopropa[3,4]benz[1,2-e]azulen-9a-yl ester, (2E)- ( | C27H36O8 | 489 | [C@]12([H])[C@@](O[H])(C(=O)C(C([H])([H])[H])=C1[H])C([H])([H])C(C([H])([H])O[H])=C([H])[C@]3([H])[C@]2(O[H])[C@]([H])(C([H])([H])[H])[C@@]([H])(OC(C([H])([H])[H])=O)[C@@](OC(=O)\C(=C([H])\C([H])([H]) [H])\C([H])([H])[H])(C4(C([H])([H])[H])C([H])([H])[H])[C@]34[H] |
| TCMBANKIN040903 | 12-O-Acetylphorbla-13-decanoate | ||||
| TCMBANKIN041061 | phorbol-12-benzoate-13-benzoate | CC1C(C2(C(C2(C)C)C3C1(C4C=C(C(=O)C4(CC(=C3)CO)O)C)O)OC(=O)C5=CC=CC=C5)OC(=O)C6=CC=CC=C6 | |||
| TCMBANKIN041106 | 2-hydroxy-3-methoxystrychnine | C22H24N2O4 | 380.4 g/mol | COC1=C(C=C2C(=C1)N3C4C25CCN6C5CC7C4C(CC3=O)OCC=C7C6)O | |
| TCMBANKIN041272 | stearic acid | 4-02-00-01206 (Beilstein Handbook Reference); AIDS-049230; Emersol 871; 8039-52-9; 126539-56-8; stearic acid, ion(1-); D00119; octadecoic acid; Hydrofol Acid 150 (VAN); 134503-33-6; Fatty acids C16-18; 68937-76-8; Kam 2000; VLZ 200; Lunac S 98; Glycon S-80; Hy-phi 1205; Lunac YA; Pristerene 9429; Pristerene 4900; Octadecanoic acid (9CI); Hystrene 9718NF; Edenor FHTI; Cetylacetic acid; NAA 173; NSC 25956; Lunac S 90; S 30C S 30C (fatty acid); Neo-Fat 18-61; Dar-chem 14; NSC25956; Edenor HT-JG 60; Octadecanoate; 57485-56-0; Oktadekansaeure; S 300 (fatty acid); Unister NAA 180; Industrene 5016; Prisorine 3508; Hydrofol Acid 150; Hystrene 4516; G 270; Stearic Acid Cherry; Century 1230; 822-16-2 (SODIUM SALT); NCGC00091596-02; Glycon S-90; 85404-83-7; NCGC00091596-01; Stearic acid (JP15/NF); Hystrene 5016; Hy-phi 1303; Glycon S-70; C01530; Octadecansaeure; Neo-Fat 18-55; WO 2 (fatty acid); Pristerene 9559; SA 200; Century 1240; Stearic acid, pure; Sunfat 18S; WO 2; CHEBI:28842; Industrene 5016K; LS-2392; Kam 3000; BRN 0608585; Edenor ST 20; AIDS049230; Lunac 30; EINECS 273-087-8; Emersol 150; 175366_SIAL; 8039-54-1; Fatty acids, C16-20; stearicacid; Stearic acid ion(1-)salt; Stearic acid (8CI); Stearinsaeure; Emersol 153NF; Hydrofol acid 1855; 57-11-4; Lunac S 30; Hystrene T 70; Prisorine 3501; Haimaric MKH(R); Stearex Beads; Groco 55; Hystrene S-97; Neo-Fat 18-54; W303518_ALDRICH; Hydrofol acid 1655; Nonsoul SN 1 (*Sodium salt*); EINECS 200-313-4; 39390-61-9; Emersol 120; EPA Pesticide Chemical Code 079082; Lunac S 20; Octadecanoic acid, ion(1-); 8013-28-3; AI3-00909; Kortacid 1895; FEMA No. 3035; Hystrene S 97; 82497-27-6; Tegostearic 254; SNA-2000 (*Sodium salt*); 1-Heptadecanecarboxylic acid; AC1MHWEJ; STL280244; 27405_RIEDEL; Steric acid; Industrene 9018; Glycon dp; F 3 (lubricant); Hy-phi 1401; Lunac S 50; Emersol 132; Stearic acid, ion(1-) (8CI); CH3-[CH2]16-COO(-); acide octadecanoique; Groco 55l; 73297_FLUKA; Serfax MT 90; Stearic acid [USAN:JAN]; 8039-51-8; acide stearique; Kam 1000; Acidum stearinicul; InChI=1/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20; 8039-53-0; 17FA; Stearophanic acid; 8037-83-0; Hystrene 7018; FA 1655; Prisorine 3502; Nonsoul SK 1; Hydrofol Acid 1895; Lunac S 40; Stearic acid 50; 8023-06-1; 85679_FLUKA; HSDB 2000; n-Octadecanoate; 400JB9103-88; Glycon tp; Unimac 5680; Loxiol G 20; Stearate; 875D; Octadecanoic acid; Neo-Fat 18-53; octadecanoate (n-C18:0); Radiacid 0427; Emery 871; Vanicol; Vis-Plus; PD 185; EINECS 250-178-0; AKOS022105769; 646-29-7; Edenor ST 1; S 300; Caswell No. 801D; Selosol 920; Tegostearic 272; Isostearic acid EX; A 1760; WLN: QV17; Stearic acid (TN); Pearl stearic; 609343-71-7; Palmitic acid - stearic acid mixture; Emersol 875; Industrene 8718; Hystrene 9718NFFG; NCGC00164255-02; ST023799; LMFA01010018; Groco 54; Edenor C18; Hystrene T-70; Hy-phi 1199; CTK8J8420; n-Octadecanoic acid; Groco 58; Pristerene 4963; Formula 300; AFCO-Chem B 65; CCRIS 2305; Industrene R; Century 1220; S4751_SIGMA; Neo-Fat 18; 58392-66-8; Barolub FTA; Hystrene 9718; CH3-[CH2]16-COOH; STE; 8037-40-9; 30399-84-9; Lunac S 90KC; Hydrofol 1895; Emery 875D; Century 1210; QIQXTHQIDYTFRH-UHFFFAOYSA-M; Neo-Fat 18-59; LS-1388; Groco 59; Humko Industrene R; Hystrene 80; Adeka Fatty Acid SA 910; Stearic acid; Prifac 2918; Emersol 6349; Edenor C 18/98; 3uex; LS-97707; CHEBI:25629; Neo-Fat 18-S; Stearic acid - palmitic acid mixture; Tegostearic 255; C-Lube 10 | C18H36O2 | 284 | C([H])([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])= O |
| TCMBANKIN041650 | phorbol-12-butyrate-13-laurate | C36H56O8 | 616.92 | CCCCCCCCCCCC(=O)OC12C(C1(C)C)C3C=C(CC4(C(C3(C(C2OC(=O)CCC)C)O)C=C(C4=O)C)O)CO | |
| TCMBANKIN041844 | phorbol | 4,9,12beta,13,20-pentahydroxytiglia-1,6-dien-3-one; 1,1a,1b,4,4a,7a,7b,8,9,9a-Decahydro-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5H-cyclopropa(3,4)benz(1,2-e)azulen-5-one (1aR-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha))-; 4beta,9alpha,12beta,13alpha,20-Pentahydroxytiglia-1,6-dien-3-one; 4beta,9alpha,1 2beta,13alpha,20-pentahydroxy-1,6-tigliadien-3-one; AIDS001981; 17673-25-5; 4beta,9alpha,12beta,13alpha,20-pentahydroxy-1,6-tigliadien-3-one; P8893_SIGMA; 4.b.-Phorbol; (4aR,7bR,8R,9R,9aR)-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-5H-cyclopropa[3,4]benzo[1,2-e]azulen-5-one; [1aR-(1aalpha,1bbeta,4 abeta,7aalpha,7balpha,8alpha,9beta,9aalpha)]-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5H-cyclopropa(3,4)benz[1,2-e]azulen-5-one; CCRIS 694; SMP2_000151; 4-.beta.-Phorbol; 5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one, 1,1aalpha,1bbeta,4,4a,7aalpha,7b,8,9,9a-decahydro-4abeta,7balpha,9beta,9a alpha-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8alpha-tetramethyl-, (+)-; 4beta-Phorbol; CHEBI:8116; AIDS-001981; (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-5H-cyclopropa[3,4]benzo[1,2-e]azulen-5-one; NSC 154778; HSDB 4328; 4-beta-Phorbol; 4,9,12beta,13,20-pentahydroxy-1,6-tigliadien-3-on; Phorbol; LMPR01040097; C09155; 5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one, 1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,6,8-tetramethyl-, (1aR-(1aalpha,1beta,4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha))-; 1,1abeta,1balpha,4,4a,7abeta,7b,8,9,9a-decahydro-4aalpha,7balpha,9beta,9aalpha-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8alpha-tetramethyl-5H-cyclopropa(3,4)benz[1,2-e]azulen-5-one; [1aR-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha)]-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5H-cyclopropa(3,4)benz[1,2-e]azulen-5-one; LS-7659 | C20H28O6 | 364 | [C@@]12(O[H])[C@]([H])([C@@]3([H])[C@@](C3(C([H])([H])[H])C([H])([H])[H])(O[H])[C@@](O[H])([H])[C@]1(C([H])([H])[H])[H])C([H])=C(C([H])([H])O[H])C([H])([H])[C@](O[H])(C(=O)C(C([H])([H])[H])=C4[H])[C@] 24[H] |
| TCMBANKIN042130 | Crotonoside | Isoguanosine (7CI,8CI); Isoguanine, 9-beta-D-ribofuranosyl-; 9H-Purin-2-ol, 6-amino-9-beta-D-ribofuranosyl-; Crotonoside; Adenosine, 1,2-dihydro-2-oxo-; ZINC04082270; PDSP1_000998; 6-amino-9-[(2R,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-2-one; Isoguanosine (VAN) (8CI); 1,2-Dihydro-2-oxoadenosine; 1818-71-9; C08432; NSC 12161; AC1OFDZ3; Isoguanosine; STOCK1N-54578; ZINC4018123; 6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]-1H-purin-2-one; 6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-purin-2-one; 6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-2-one; 6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-1H-purin-2-one; PDSP2_000982 | 283.24 g/mol | ||
| TCMBANKIN042513 | monotropein | NSC 88926; NSC 291303; (1S,4aS,7R,7aS)-7-hydroxy-7-(hydroxymethyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4a,7a-dihydro-1H-cyclopenta[d]pyran-4-carboxylic acid; (1S,4aS,7R,7aS)-7-hydroxy-7-(hydroxymethyl)-1-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4a,7a-dihydro-1H-cyclopenta[d]pyran-4-carboxylic acid; (1S,4aS,7R,7aS)-7-hydroxy-7-(hydroxymethyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1H-cyclopenta[d]pyran-4-carboxylic acid; 5945-50-6; monotropein; LMPR01020113; C09788; (1S,4aS,7R,7aS)-7-hydroxy-7-methylol-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-4a,7a-dihydro-1H-cyclopenta[d]pyran-4-carboxylic acid; Monotropein (8CI); Cyclopenta(c)pyran-4-carboxylic acid, 1-(beta-D-glucopyranosyloxy)-1,4a,7,7a-tetrahydro-7-hydroxy-7-(hydroxymethyl)-, (1S-(1alpha,4aalpha,7beta,7aalpha))- (9CI) | C16H22O11 | 390.339 | [C@]1([H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O2)OC([H])=C(C(O[H])=O)[C@@]([H])(C([H])=C([H])[C@]3(O[H])C([H])([H])O[H])[C@]13[H] |
| TCMBANKIN043096 | 1,6-Dihydroxy-2-methoxyanthraquinone | 1,6-dihydroxy-2-methoxyanthraquinone; AK593134; DTXSID70162205; CTK4C3349; 142878-32-8; ACMC-1C658; AC1L314V; AKOS030561427; 1,6-dihydroxy-2-methoxy-anthracene-9,10-dione; 9,10-Anthracenedione,1,6-dihydroxy-2-methoxy-; SCHEMBL3276344; 1,6-dihydroxy-2-methoxy-9,10-anthraquinone; 1,6-Dhma; 1,6-dihydroxy-2-methoxyanthracene-9,10-dione | 270.24 g/mol | ||
| TCMBANKIN043304 | Croweacin | croweacin; 4-Methoxy-5-(2-propen-1-yl)-1,3-benzodioxole; Benzene, 1-allyl-2-methoxy-3,4-(methylenedioxy)-; 5-allyl-4-methoxy-1,3-benzodioxole; UNII-WS97V62VOQ; 484-34-4; WS97V62VOQ; SCHEMBL2416220; 4-methoxy-5-prop-2-enyl-1,3-benzodioxole; 1,3-Benzodioxole, 4-methoxy-5-(2-propenyl)-; 1,3-Benzodioxole, 4-methoxy-5-(2-propen-1-yl)-; AC1NSTXG | C11H12O3 | 192.21 | COC1=C(C=CC2=C1OCO2)CC=C |
| TCMBANKIN043467 | phorbol-12-tiglate-13-caprylenate | ||||
| TCMBANKIN043474 | neoclerodan-5,10-en-19,6β;20,12-diolide | C20H22O5 | CC1CC2C3=C(C14CC(OC4=O)C5=COC=C5)CCCC3(C(=O)O2)C | ||
| TCMBANKIN043524 | Phorbol-12-caprate-13-acetate | ||||
| TCMBANKIN043553 | 1,6-dihydroxy-2,4-dimethoxyanthraquinone | 142878-33-9; 1,6-Ddma; 9,10-Anthracenedione, 1,6-dihydroxy-2,4-dimethoxy-; 1,6-dihydroxy-2,4-dimethoxyanthracene-9,10-dione; 1,6-dihydroxy-2,4-dimethoxy-9,10-anthraquinone; 1,6-Dihydroxy-2,4-dimethoxyanthraquinone V; 1,6-dihydroxy-2,4-dimethoxy-anthracene-9,10-dione | C16H12O6 | 300.263 | c1(O[H])c(C(=O)c(c([H])c([H])c(O[H])c2[H])c2C3=O)c3c(OC([H])([H])[H])c([H])c1OC([H])([H])[H] |
| TCMBANKIN043707 | 13-O-Acetylphorbol-20-linoleate | 9,12-Octadecadienoic acid (9Z,12Z)-, ((1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b,9-trihydroxy-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-3-yl)methyl ester; 13-O-Acetylphorbol-20-(9Z,12Z)-octadecadienoate; 13-0-Acetylphorbol-20-linoleate; 13-O-Acetylphorbol-20-linoleate; 250268-53-2; (acetoxy-trihydroxy-tetramethyl-oxo-[?]yl)methyl (9Z,12Z)-octadeca-9,12-dienoate; 9,12-Octadecadienoic acid (9Z,12Z)-, [(1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b,9-trihydroxy-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-3-yl]methyl ester; CHEMBL2375782 | 668.9 g/mol | ||
| TCMBANKIN043877 | Phorbol-12-tiglate-13-butyrate | ||||
| TCMBANKIN043932 | phorbol-12-α-methylbutyrate-13-laurate | ||||
| TCMBANKIN045661 | Asperuloside tetraacetate | C11655; AC1L9EGQ; asperuloside tetraacetate; CHEBI:2882 | C26H30O15 | 582.51 | CC(=O)OCC1C(C(C(C(O1)OC2C3C4C(C=C3COC(=O)C)OC(=O)C4=CO2)OC(=O)C)OC(=O)C)OC(=O)C |
| TCMBANKIN045973 | Phorbol-12-α-methylbutyrate-13-caprylenate | ||||
| TCMBANKIN047089 | raffinose | Melitriose, Raffinose; alpha-D-Glucopyranoside, beta-D-fructofuranosyl O-alpha-D-galactopyranosyl (1 to 6)-; 6G-alpha-D-galactosylsucrose; alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranosyl beta-D-fructofuranoside; Gossypose; alpha-D-glucopyranoside, beta-D-fructofuranosyl O-alpha-D-galactopyranosyl-(1->6)-; 17629-30-0; alpha-D-Galp-(1->6)-alpha-D-Glcp-(1<->2)-beta-D-Fruf; alpha-D-Glucopyranoside, beta-D-fructofuranosyl O-alpha-D-galactopyranosyl-(1>6)- (9CI); beta-D-Fructofuranosyl-O-alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside; Raffinose; CHEBI:16634; 512-69-6; AIDS-014662; (2R,3R,4S,5S,6R)-2-[[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)-2-tetrahydrofuranyl]oxy]-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxymethyl]tetrahydropyran-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-dimethylol-tetrahydrofuran-2-yl]oxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-3,4,5-triol; SCHEMBL16435154; O-alpha-D-Galactopyranosyl(1,6)-O-alpha-D-glucopyranosyl-(1,2)-beta-D-fructofuranoside; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl]oxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxane-3,4,5-triol; C00492; beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside; AIDS014662 | C18H32O16 | 504 | O([H])C([H])([H])[C@]1([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(OC([H])([H])[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[C@@]3(O[C@]([H])(C([H])([H])O[H])[ C@@]([H])(O[H])[C@]3([H])O[H])C([H])([H])O[H])O2)O1 |
| TCMBANKIN047219 | Phorbol-12-tiglate-13-laurate | 628.93 | |||
| TCMBANKIN047859 | 12-o-(2-methylbutyryl)phorbol-13-dodecanoate | CCCCCCCCCCCC(=O)OC12C(C1(C)C)C3C=C(CC4(C(C3(C(C2OC(=O)C(C)CC)C)O)C=C(C4=O)C)O)CO | |||
| TCMBANKIN048701 | phorbol-12-laurate-13-acetate | CCCCCCCCCCCC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)OC(=O)C)O)C | |||
| TCMBANKIN050399 | Phorbol-12-α-methylbutyrate-13-caprate | ||||
| TCMBANKIN057941 | l-ascorbic acid;ascorbicacid | l-ascorbic acid;ascorbic acid ; LS-187838 | C6H8O6 | 176.12 g/mol | C(C(C1C(=C(C(=O)O1)O)O)O)O |
| TCMBANKIN058247 | Phloretol | Phloretin; EU-0101012; Dihydronaringenin; KBioGR_001803; 3-(4-Hydroxy-phenyl)-1-(2,4,6-trihydroxy-phenyl)-propan-1-one; CCRIS 7459; BCBcMAP01_000040; SDCCGMLS-0066637.P001; .beta.-(p-Hydroxyphenyl)phloropropiophenone; SMP1_000238; 79310_FLUKA; NCGC00094304-03; AIDS-052153; 2',4',6'-Trihydroxy-3-(p-hydroxyphenyl)propiophenone; Propiophenone, 2',4',6'-trihydroxy-3-(p-hydroxyphenyl)- (8CI); DivK1c_006429; KBioSS_001775; NSC 407292; CHEBI:17276; KBio3_002071; EINECS 200-488-7; KBio2_006911; P7912_SIGMA; AIDS052153; KBio1_001373; Spectrum3_001036; 2',4',6'-Trihydroxy-3-(4-Hydroxyphenyl)propiophenone; beta-(4-Hydroxyphenyl)-2,4,6-trihydroxypropiophenone; Spectrum5_001698; 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-1-propanone; Lopac0_001012; Spectrum2_000681; Lopac-P-7912; NCGC00015840-01; beta-(p-Hydroxyphenyl)phloropropiophenone; SMR000326783; G50; 3-(4-Hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one; SPECTRUM300554; 2′,4′,6′-Trihydroxy-3-(4-hydroxyphenyl)propiophenone; beta-(p-Hydroxyphenyl)-2,4,6-trihydroxypropiophenone; MLS000728507; KBio2_004343; Propiophenone, 2',4',6'-trihydroxy-3-(p-hydroxyphenyl)-; Oprea1_824722; TNP00255; 60-82-2; SpecPlus_000333; NCGC00015840-02; 2′,4′,6′-Trihydroxy-3-p-hydroxyphenylpropiophenone; ST057164; BSPBio_002851; KBio2_001775; NCGC00094304-02; C00774; ZINC00047553; SPBio_000801; Spectrum_001295; 1-Propanone, 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-; Spectrum4_001172; NSC407292; .beta.-(p-Hydroxyphenyl)-2,4,6-trihydroxypropiophenone; phloretin | C15H14O5 | 274.27 g/mol | C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2O)O)O)O |
| TCMBANKIN058248 | phloridzin;Phlorizin | phloretin 2'-O-glucoside;1-propanone, 1-[2-(beta-D-glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-; ZINC03875408; C01604; 1-[2,4-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)propan-1-one; KBio2_001771; 1-[2-(.beta.-D-Glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone; KBioSS_001771; KBioGR_002141; Spectrum_001291; 4,6-dihydroxy-2-(beta-D-glucosido)-beta-(p-hydroxyphenyl)propiophenone; 60-81-1; Spectrum4_001651; SPBio_000881; 2'-(beta-D-Glucopyranosyloxy)-4',6'-dihydroxy-3-(4-hydroxyphenyl)propiophenone; AIDS-009884; KBio2_004339; AIDS009884; 16055-86-0; AI3-19835; KBio2_006907; Spectrum3_001227; SpecPlus_000325; EINECS 200-487-1; 1-[2,4-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-phenyl]-3-(4-hydroxyphenyl)propan-1-one; 1-[2,4-dihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]phenyl]-3-(4-hydroxyphenyl)propan-1-one; 1-[2,4-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-phenyl]-3-(4-hydroxyphenyl)propan-1-one; phlorizin; Phlorhizin; Phloridzosid; Phlorhizin;Phlorizin; DivK1c_006421; SDCCGMLS-0066626.P001; Phloretin 2'-glucoside; 52276-56-9; KBio1_001365; Phloretin-2'-beta-glucoside; BSPBio_002674; Phloridzin; SBB005924; NCGC00142423-01; KBio3_002174; NSC 2833; Phlorrhizen; 3,5-dihydroxy-2-[3-(4-hydroxyphenyl)propanoyl]phenyl beta-D-glucopyranoside; 1-Propanone, 1-(2-(beta-D-glucopyranosyloxy)-4,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)-; Spectrum5_000521; 1-[2,4-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-phenyl]-3-(4-hydroxyphenyl)propan-1-one; Floridzin; CHEBI:8113; Spectrum2_000701; 112318-65-7; SPECTRUM300547; 2'-(.beta.-D-glucopyranosyloxy)-4',6'-dihydroxy-3-(4-hydroxyphenyl)propiophenone | C21H24O10 | 436.4 g/mol | C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2OC3C(C(C(C(O3)CO)O)O)O)O)O)O |
| TCMBANKIN058277 | 2-hydroxybenzoic acid | O-hydroxybenzoic acid; 3- coffee acid; Thick-stemmed black base | C7H6O3 or HOC6H4COOH | 138.12 g/mol | C1=CC=C(C(=C1)C(=O)O)O |
| TCMBANKIN058386 | α-hydroxyanthraquinone | MolPort-002-132-411; WLN: L C666 BV IVJ DQ; InChI=1/C14H8O3/c15-11-7-3-6-10-12(11)14(17)9-5-2-1-4-8(9)13(10)16/h1-7,15; KS-00000Z2X; C-35429; 1-HYDROXYANTHRAQUINONE; 1-Hydroxyanthra-9,10-quinone #; 129H431; ACMC-1BT7T; 1-hydroxy-anthracene-9,10-dione; 1-Hydroxyanthrachinon [Czech]; 1-oxidanylanthracene-9,10-dione; FT-0730299; W-108363; NSC 8640; 1-hydroxy-9,10-dihydroanthracene-9,10-dione; EINECS 204-946-7; LS-7444; SCHEMBL145303; 23077-99-8; CTK3J2539; alpha-Hydroxyanthraquinone; M-8246; BRN 1912751; 1-hydroxy-10-anthracenedione; AKOS015856426; 1-hydroxy-anthraquinon; 10-anthracenedione,1-hydroxy-9; LFU129OE9H; CS-W000838; 1-Hydroxy anthraquinone; CTK0J5861; Ambcb5134246; AC1L1R5P; NSC8640; AJ-46464; 1-hydroxy-9,10-anthracenedione; AK-57203; CHEMBL501834; 9-HYDROXYANTHRACENE-1,10-DIONE; A805939; 1-Hydroxyanthrachinon; KB-66266; 9,10-Anthracenedione, 1-hydroxy-; 1-Hydroxy-9,10-anthraquinone; 1-hydroxy-anthraquinone; ST2408786; DTXSID1020722; Jsp001799; TR-004067; AX8059040; BTLXPCBPYBNQNR-UHFFFAOYSA-N; 1,10-Anthracenedione, 9-hydroxy-; ANW-19128; RTR-004067; MFCD00058946; GS-3366; 1-hydroxyanthracene-9,10-dione; 9, 1-hydroxy-; CBDivE_013840; 1-Hydroxyanthra-9,10-quinone; MCULE-6359940891; I08-1081; Hydroxyanthraquinone; 9-hydroxy-1,10-anthraquinone; P224; NSC-8640; 4CH-014563; BG01526671; alpha-hydroxyanthraquinone; BDBM50025501; Anthraquinone, 1-hydroxy-; CC-04623; ZINC3875850; UNII-LFU129OE9H; AN-43639; .alpha.-Hydroxyanthraquinone; C02980; CCRIS 3694; CHEBI:28877; HSDB 7145; 129-43-1; 1-Hydroxyanthra-9,10-quinone, AldrichCPR; 4-hydroxyanthraquinone | C14H8O3 | 224.21 g/mol | C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=CC=C3)O |
| TCMBANKIN058458 | crotonoside | crotonside; Isoguanosine (7CI,8CI); Isoguanine, 9-beta-D-ribofuranosyl-; 9H-Purin-2-ol, 6-amino-9-beta-D-ribofuranosyl-; Crotonoside; Adenosine, 1,2-dihydro-2-oxo-; Crotonside; isoguanosine ZINC04082270; PDSP1_000998; 6-amino-9-[(2R,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-2-one; Isoguanosine (VAN) (8CI); 1,2-Dihydro-2-oxoadenosine; 1818-71-9; C08432; NSC 12161; AC1OFDZ3; Isoguanosine; STOCK1N-54578; ZINC4018123; 6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]-1H-purin-2-one; 6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-purin-2-one; 6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-2-one; 6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-1H-purin-2-one; PDSP2_000982 | C10H13N5O5 | 283.24 g/mol | C1=NC2=C(NC(=O)N=C2N1C3C(C(C(O3)CO)O)O)N |
| TCMBANKIN058570 | ohioensin a | BDBM50374279; AC1L9D0W; Ohioensin A; 121353-47-7; Ohioensin-A; CHEBI:7732; CHEMBL403093; DTXSID80331864; C09956; D03EGZ;C09956; 121353-47-7; Ohioensin A | C23H16O5 | 372.4 g/mol | C1C2C3C(C4=C(C=CC(=C4)O)C5=C3C(=C(C=C5O)O)C1=O)OC6=CC=CC=C26 |
| TCMBANKIN059396 | Tigloidine;3alpha-Tigloyloxytropane | tigloidine;3alpha-tigloyloxytropane | C13H21NO2 | 223.31g/mol | CC=C(C)C(=O)OC1CC2CCC(C1)N2C |
| TCMBANKIN059428 | BEO | C4H6O2 | 86.09 g/mol | CC=CC(=O)O | |
| TCMBANKIN059743 | Morindon | C15H10O5 | 270.24 g/mol | CC1=C(C2=C(C=C1)C(=O)C3=C(C2=O)C=CC(=C3O)O)O | |
| TCMBANKIN059745 | 1-hydroxy-2-methyl-anthraquinone | C15H10O3 | 238.24 g/mol | CC1=C(C2=C(C=C1)C(=O)C3=CC=CC=C3C2=O)O | |
| TCMBANKIN059929 | physcion | C16H12O5 | 284.26 g/mol | CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)OC | |
| TCMBANKIN060691 | poriferast-5-en-3beta-ol;22,23-dihydrostigmasterol;gamma-sitosterol;clionasterol;beta-dihydrofucosterol | C29H50O | 414.71 g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060705 | methyl linoleate | C19H34O2 | 294.47 | CCC=CCC=CCC=CCCCCCCCC(=O)OC | |
| TCMBANKIN060879 | Linolic acid | C18H32O2 | 280.4 g/mol | CCCCCC=CCC=CCCCCCCCC(=O)O | |
| TCMBANKIN060958 | oleic acid;cis-oleic acid;oleinic acid | C18H34O2 | 282.46 | CCCCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN060969 | Erucic acid | C22H42O2 | 338.57 | CCCCCCCCC=CCCCCCCCCCCCC(=O)O | |
| TCMBANKIN060980 | caproic acid;capric acid;n-decanoic acid;NON | C10H20O2 | 172.26 g/mol | CCCCCCCCCC(=O)O | |
| TCMBANKIN060982 | Phorbol caprate, tiglate | C35H52O8 | 600.78 | CCCCCCCCCC(=O)OC12C(C1(C)C)C3C=C(CC4(C(C3(C(C2OC(=O)C(=CC)C)C)O)C=C(C4=O)C)O)CO | |
| TCMBANKIN060983 | Phorbol acetate, caprate | C32H48O8 | 560.72 g/mol | CCCCCCCCCC(=O)OC12C(C1(C)C)C3C=C(CC4(C(C3(C(C2OC(=O)C)C)O)C=C(C4=O)C)O)CO | |
| TCMBANKIN061006 | lauric acid | C12H24O2 | 200.32 | CCCCCCCCCCCC(=O)O | |
| TCMBANKIN061007 | AIDS161963 | C34H52O8 | 588.8 g/mol | CCCCCCCCCCCC(=O)OC12C(C1(C)C)C3C=C(CC4(C(C3(C(C2OC(=O)C)C)O)C=C(C4=O)C)O)CO | |
| TCMBANKIN061014 | n-dodecanal | C12H24O | 184.32 g/mol | CCCCCCCCCCCC=O | |
| TCMBANKIN061029 | myristic acid | C14H28O2 | 228.37 | CCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061032 | phorbol 12-myristate 13-acetate | C8H8HgO2 | 616.8 g/mol | CCCCCCCCCCCCCC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)OC(=O)C)O)C | |
| TCMBANKIN061071 | Ethylpalmitate | C18H36O2 | 284.5 g/mol | CCCCCCCCCCCCCCCC(=O)OCC | |
| TCMBANKIN061091 | stearic acid | CH3(CH2)16COOH | 284.5 g/mol | CCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061095 | TGL | C57H110O6 | 891.5 g/mol | CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC | |
| TCMBANKIN061105 | Eicosanoic acid | C20H40O2 | 312.53 g/mol | CCCCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061118 | behenic acid | C22H44O2 | 340.6 g/mol | CCCCCCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061500 | (2r,3s)-(+)-3',5-dihydroxy-4',7-dimethoxydihydroflavonol | 4',7-di-o-methyldihydroquercetin | C17H16O7 | COC1=C(C=C(C=C1)C2C(C(=O)C3=C(C=C(C=C3O2)OC)O)O)O | |
| TCMBANKIN061714 | 1,6-Dihydroxy-2,4-dimethoxyanthraquinone | 142878-33-9; 1,6-Ddma; 9,10-Anthracenedione, 1,6-dihydroxy-2,4-dimethoxy-; 1,6-dihydroxy-2,4-dimethoxyanthracene-9,10-dione; 1,6-dihydroxy-2,4-dimethoxy-9,10-anthraquinone; 1,6-Dihydroxy-2,4-dimethoxyanthraquinone V; 1,6-dihydroxy-2,4-dimethoxy-anthracene-9,10-dione; 1,6-dihydroxy-2,4-dimethoxyanthranquinone v; 1,6-dihydroxy-2,4-dimethoxyanthraquinone v | C16H12O6 | 300.26 g/mol | COC1=CC(=C(C2=C1C(=O)C3=C(C2=O)C=CC(=C3)O)O)OC |
| TCMBANKIN061805 | myristicin; 1,3-Benzodioxole,4-methoxy-6-(2-propenyl)-; asaricin | 4-Methoxy-6-(2-propenyl)-1,3-benzodioxole; 04PD6CT78W; BNWJOHGLIBDBOB-UHFFFAOYSA-N; 4-methoxy-6-prop-2-enyl-1,3-benzodioxole; 1,3-Benzodioxole, 4-methoxy-6-(2-propenyl)-; V0156; STK693140; Myristicin, analytical standard; ZB013050; Myristicin from parsley leaf oil, >=85% (HPLC), oil; UNII-04PD6CT78W; CCG-208543; NCGC00257726-01; Myristicin; 4-Methoxy-6-[2-propenyl]-1,3-benzodioxole; C10480; FCH920323; 6-Allyl-4-methoxy-1,3-benzodioxole; Myristicine; Benzene, 5-allyl-1-methoxy-2,3-(methylenedioxy)-; HMS2270K14; SCHEMBL68041; BRN 0166218; NCGC00091427-03!4-methoxy-6-prop-2-enyl-1,3-benzodioxole; DSSTox_RID_77884; 1,3-Benzodioxole, 4-methoxy-6-(2-propenyl)- (9CI); SBB014760; CAS-607-91-0; 607M910; SR-01000838340-3; 1-Allyl-3-methoxy-4,5-methylenedioxybenzene; M9411_SIGMA; 6-allyl-4-methoxy-1,3-benzodioxol; 1-Methoxy-2,3-methylenedioxy-5-(2-propenyl)benzene; ZERO/009047; AKOS005604763; Myristicin (6CI); MFCD00133549; Myristicin from parsley leaf oil; LS-2163; DSSTox_CID_5693; MLS001065535; MCULE-6209105333; 607-91-0; 4-methoxy-6-(prop-2-en-1-yl)-1,3-benzodioxole; CHEBI:68234; DSSTox_GSID_25693; CCRIS 6782; Tox21_200172; 5-Allyl-2,3-(methylendioxy)anisole; 4-methoxy-6-prop-2-enyl-2H-benzo[d]1,3-dioxolene; 4-Methoxy-6-(2-propenyl)-1,3-benzodioxole, 9CI; ST097616; 3-methoxy,4,5-methylenedioxy-allylbenzene; EINECS 210-146-9; 5-Allyl-1-methoxy-2,3-(methylenedioxy)-Benzene; NCGC00091427-02; MolPort-003-925-569; 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole; CHEMBL481044; SC-21462; SMR000112534; API0025964; CTK5J3915; HSDB 3516; AC1L1HSS; AN-46392; ZINC403089; DTXSID1025693; FT-0672575; 5-19-02-00631 (Beilstein Handbook Reference); 09237_FLUKA; 5-Allyl-1-methoxy-2,3-(methylenedioxy)benzene; SR-01000838340; NCGC00091427-01; myristicin; 1-allyl-3,4-methylenedioxy-5-methoxybenzene | C11H12O3 | 192.21 g/mol | COC1=CC(=CC2=C1OCO2)CC=C |
| TCMBANKIN061957 | 1-Hydroxyanthraquinone | 1- hydroxyl-7hydroxymethylanthraquinone; α-hydroxyanthraquinone; Hydroxyanthraquinone | C14H8O3 | C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=CC=C3)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab